Tom Brophy Buys 5 Shares of Croda International (LON:CRDA) Stock

Key Points

• Insider trade: Tom Brophy purchased 5 shares of Croda on April 10 at GBX 2,950 each (total £147.50) and had earlier sold 1,020 shares on March 17 at GBX 2,652 (≈£27,050.40), showing a small recent purchase following a larger disposal.
• Stock snapshot: CRDA traded at GBX 2,929.50 (midday), with a 1‑year range of GBX 2,426.77–3,312, a market cap of £4.08bn and a trailing P/E of ~66.
• Analyst view: Morgan Stanley upgraded Croda to "overweight" and raised its target to GBX 3,350; consensus is a "Moderate Buy" with an average target of GBX 3,140 (three Buy, three Hold).

Croda International Plc (LON:CRDA - Get Free Report) insider Tom Brophy purchased 5 shares of the business's stock in a transaction on Friday, April 10th. The shares were bought at an average cost of GBX 2,950 per share, for a total transaction of £147.50.

Tom Brophy also recently made the following trade(s):

• On Tuesday, March 17th, Tom Brophy sold 1,020 shares of Croda International stock. The stock was sold at an average price of GBX 2,652, for a total value of £27,050.40.

Croda International Stock Performance

CRDA traded down GBX 37.50 during midday trading on Monday, hitting GBX 2,929.50. 188,028 shares of the company were exchanged, compared to its average volume of 3,003,397. Croda International Plc has a 1-year low of GBX 2,426.77 and a 1-year high of GBX 3,312. The company has a current ratio of 1.99, a quick ratio of 2.25 and a debt-to-equity ratio of 31.85. The firm has a market capitalization of £4.08 billion, a price-to-earnings ratio of 65.98, a price-to-earnings-growth ratio of 1.40 and a beta of 0.94. The company's 50 day simple moving average is GBX 2,877.49 and its 200 day simple moving average is GBX 2,806.06.

Croda International (LON:CRDA - Get Free Report) last announced its quarterly earnings results on Tuesday, February 24th. The company reported GBX 146.20 earnings per share for the quarter. Croda International had a return on equity of 2.82% and a net margin of 3.65%. As a group, sell-side analysts predict that Croda International Plc will post 181.8307268 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the company. Morgan Stanley raised Croda International to an "overweight" rating and upped their price target for the stock from GBX 3,280 to GBX 3,350 in a report on Wednesday, March 25th. Deutsche Bank Aktiengesellschaft reduced their price target on Croda International from GBX 3,100 to GBX 3,000 and set a "hold" rating for the company in a report on Tuesday, March 24th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of GBX 3,140.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.